東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Osteoporosis- Chemotherapy" ]

切換: 標籤 | MARC模式 | ISBD

Medication-related osteonecrosis of ...

Otto, Sven.

FindBook

Google Book

Amazon

博客來

Medication-related osteonecrosis of the jaws = bisphosphonates, denosumab, and new agents /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Medication-related osteonecrosis of the jaws/ edited by Sven Otto.
其他題名:	bisphosphonates, denosumab, and new agents /
其他作者:	Otto, Sven.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2015.,
面頁冊數:	viii, 220 p. :ill. (some col.), digital ;24 cm.
內容註:	Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.
Contained By:	Springer eBooks
標題:	Jaws - Necrosis. -
電子資源:	http://dx.doi.org/10.1007/978-3-662-43733-9
ISBN:	9783662437339 (electronic bk.)

Medication-related osteonecrosis of the jaws = bisphosphonates, denosumab, and new agents /
Medication-related osteonecrosis of the jawsbisphosphonates, denosumab, and new agents /[electronic resource] :edited by Sven Otto. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - viii, 220 p. :ill. (some col.), digital ;24 cm.

Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.

Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.

ISBN: 9783662437339 (electronic bk.)

Standard No.: 10.1007/978-3-662-43733-9doiSubjects--Topical Terms:

1566823
Jaws
--Necrosis.

LC Class. No.: RC936

Dewey Class. No.: 615.7042

Medication-related osteonecrosis of the jaws = bisphosphonates, denosumab, and new agents /
LDR:02923nmm a2200313 a 4500 001 1993871
003 DE-He213
005 20150724155644.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783662437339 (electronic bk.)
020 $a 9783662437322 (paper)
024 7 $a 10.1007/978-3-662-43733-9 $2 doi
035 $a 978-3-662-43733-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC936
072 7 $a MMDS $2 bicssc
072 7 $a MED085020 $2 bisacsh
082 0 4 $a 615.7042 $2 23
090 $a RC936 $b .M489 2015
245 0 0 $a Medication-related osteonecrosis of the jaws $h [electronic resource] : $b bisphosphonates, denosumab, and new agents / $c edited by Sven Otto.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a viii, 220 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.
520 $a Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.
650 0 $a Jaws $x Necrosis. $3 1566823
650 0 $a Cancer $x Chemotherapy $x Complications. $3 2018792
650 0 $a Osteoporosis $x Chemotherapy $x Complications. $3 2132408
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Oral and Maxillofacial Surgery. $3 890909
650 2 4 $a Dentistry. $3 828971
700 1 $a Otto, Sven. $3 2132407
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-43733-9
950 $a Medicine (Springer-11650)